The targeted markers, ESAM, CD106, CD201, VEGF-A, and VEGFR-2, whose elevated expression is associated with inflammation and endothelial dysfunction were indeed upregulated at 4 dpi (Figure 6A). This evidence concerns the gene PROCR and endothelial dysfunction.